TJC0265
Pulmonary fibrosis
PreclinicalActive
Key Facts
About TaiwanJ Pharmaceuticals
TaiwanJ develops small‑molecule drugs for liver and inflammatory diseases using proprietary TLR4/Autotaxin platforms.
View full company profileTherapeutic Areas
Other Pulmonary fibrosis Drugs
| Drug | Company | Phase |
|---|---|---|
| Zelpultide Alfa | Airway Therapeutics | Pre-clinical/Research |
| TeloAT2 | Rejuvenation Technologies | Phase 1 |